Somatic mosaicism in ACVRL1 with transmission to several offspring affected with severe pulmonary arterial hypertension

@article{Jones2014SomaticMI,
  title={Somatic mosaicism in ACVRL1 with transmission to several offspring affected with severe pulmonary arterial hypertension},
  author={Gabriela E Jones and Lisa Robertson and Rachel E. Harrison and Cheryl K. Ridout and Pradeep C. Vasudevan},
  journal={American Journal of Medical Genetics Part A},
  year={2014},
  volume={164},
  pages={2121 - 2123}
}
Somatic Mosaicism in ACVRL1 With Transmission to Several Offspring Affected With Severe Pulmonary Arterial Hypertension Gabriela Jones,* Lisa Robertson, Rachel Harrison, Cheryl Ridout, and Pradeep Vasudevan Clinical Genetics Department, University Hospitals Leicester NHS Trust, Leicester, United Kingdom Clinical Genetics Department, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom DNA Laboratory, Guy’s Hospital, London, United Kingdom 

Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects

TLDR
These analyses represent the largest comprehensive compilation of BMPR2 and associated genetic risk factors for PAH, comprising known and novel variation, and with the inclusion of an allelic series of locus‐specific variation in BMPR1 provide a key resource in data interpretation and development of contemporary therapeutic and diagnostic tools.

Hereditary hemorrhagic telangiectasia with bilateral pulmonary vascular malformations: A case report.

TLDR
Embolization is the method of choice in the treatment of arteriovenous malformations with minor adverse effects and very satisfying therapeutic effect and HHT is a rare dominant inherited multisystem disease that requires multidisciplinary approach to diagnosis and treatment.

Novel ACLV1 Mutation Identified in Late Onset Hereditary Hemorrhagic Telangiectasia

TLDR
A 62-year-old patient with a rare, late-onset disease course featuring a novel mutation in ACVRL1, a signal transducer in the TGFβ/BMP pathway is presented.

Novel ACLV 1 Mutation Identified in Late Onset Hereditary Hemorrhagic Telangiectasia

TLDR
A 62-year-old patient with a rare, late-onset disease course featuring a novel mutation in ACVRL1, a signal transducer in the TGFβ/BMP pathway is presented.

Molecular Research in Chronic Thromboembolic Pulmonary Hypertension

TLDR
This review summarises the current knowledge regarding genetic differences between CTEPH patients and controls and suggests mutations in BMPR2, differential gene and microRNA expression, and the transcription factor FoxO1 have been suggested to be involved in the processes underlying the development ofCTEPH.

AI (Artificial Intelligence) and Hypertension Research

  • F. Mueller
  • Biology, Medicine
    Current Hypertension Reports
  • 2020
TLDR
Basic and clinical research taking advantage of new gene sequencing-based tools, to uncover mechanisms how complex protein networks regulate blood pressure in health and disease, will be critical to lift hypertension research and management from its stagnation.

References

SHOWING 1-10 OF 30 REFERENCES

ACVRL1 germinal mosaic with two mutant alleles in hereditary hemorrhagic telangiectasia associated with pulmonary arterial hypertension

TLDR
ACVRL1 germinal mosaic with two mutant alleles in hereditary hemorrhagic telangiectasia associated with pulmonary arterial hypertension and its consequences are described.

Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension

TLDR
The critical role of the TGF-β signalling pathway in this condition is highlighted andDexfenfluramine associated pulmonary arterial hypertension occurring in a patient with hereditary haemorrhagic telangiectasia related to a mutation within the endoglin gene is described.

Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia

TLDR
The present data bring to 10 the number of reported families with primary pulmonary hypertension and hereditary haemorrhagic telangiectasia type 2, representing 16% of the 61 families with known activin receptor-like kinase 1 mutations.

A novel channelopathy in pulmonary arterial hypertension.

TLDR
It is shown that two sequential chromothripsis-like events can occur in a single tumor-cell lineage, and data supporting a clonal relationship between separate leiomyomas occurring in the same patient is described.

Identification of clinically relevant mosaicism in type I hereditary haemorrhagic telangiectasia

TLDR
The results show the importance of investigating patients without prior family history for the presence of mutational mosaicism, as detecting this would enable appropriate genetic screening and targeted medical care for at-risk children of mosaic patients.

Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation.

TLDR
ACVRL1 mutation carriers were characterized by a younger age at PAH diagnosis and had worse prognosis compared with other patients with PAH, suggesting more rapid disease progression.

Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension.

TLDR
The pattern of inheritance in a large number of families in an attempt to find clues to pathogenesis was examined, finding the disease has highly variable penetrance among families.

Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene.

TLDR
The findings indicate that the bone morphogenetic protein-signaling pathway is defective in patients with primary pulmonary hypertension and may implicate the pathway in the nonfamilial forms of the disease.

A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension

TLDR
The involvement of SMAD8 in the pathogenesis of PAH is suggested as well as mutations in other genes of the TGF-β/BMP signalling pathways which may also predispose to PAH.